What do doctors typically charge for Injection Filgrastim-ayow Biosimilar Releuko 1 Microgram?

The nationwide median physician charge for Injection Filgrastim-ayow Biosimilar Releuko 1 Microgram (HCPCS Q5125) is $1.75. Doctor billed charges vary based on geographic region, setting, and overhead.

What is the standard insurance baseline for HCPCS Q5125?

The standard insurance baseline reimbursement rate is $0.55. This represents the customary allowable amount established across standard fee schedules.

Home/Procedures/Injection Filgrastim-ayow Biosimilar Releuko 1 Microgram

HCPCS Q5125Medical Service

Injection Filgrastim-ayow Biosimilar Releuko 1 Microgram

Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram. Clinical pricing breakdown and utilization metrics across 43 practicing doctors nationwide.

$1.75

Peer Median Charge

Gross billed rate

$0.55

Standard Baseline

Customary allowable

3.2x

National Markup

Charge vs baseline

Active Physicians

Billing this code

Planning care or already received a bill for CPT Q5125?Calculate total facility bundle costs or generate an assertive dispute settlement offer.

Calculate Bundled Cost →Dispute an Inflated Bill 🧾

Understanding This Medical Fee

Gross Charge vs Negotiated Payment: The median physician charge for this service is $1.75. However, insured patients almost never pay this full amount directly. Insurers negotiate rates down toward the $0.55 baseline.

Self-Pay & Uninsured Guidance: If you are paying without insurance or out-of-network, request a prompt-pay cash discount. Most medical practices are willing to settle self-pay bills near the customary baseline rate rather than the full gross charge.

Key Questions for Your Doctor's Billing Office:

"Does Dr. [Name] participate in my specific insurance plan network?"
"What is the total self-pay or cash rate for code Q5125 if paid upfront?"
"Are there separate facility, anesthesia, or pathology fees associated with this procedure?"